Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic Syndrome

Patients with the metabolic syndrome (MetS) have impaired insulin-induced enhancement of vasodilator responses. The incretin hormone glucagon-like peptide 1 (GLP-1), beyond its effects on blood glucose, has beneficial actions on vascular function. This study, therefore, aimed to assess whether GLP-1...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2013-03, Vol.36 (3), p.683-689
Hauptverfasser:	TESAURO, Manfredi, SCHINZARI, Francesca, CAMPIA, Umberto, CARDILLO, Carmine, ADAMO, Angelo, ROVELLA, Valentina, MARTINI, Francesca, MORES, Nadia, BARINI, Angela, PITOCCO, Dario, GHIRLANDA, Giovanni, LAURO, Davide
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetylcholine - pharmacology Biological and medical sciences Cardiovascular disease Complications and side effects Development and progression Diabetes Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Genetic aspects Glucagon-Like Peptide 1 - pharmacology Glucose - metabolism Humans Hyperinsulinism - metabolism Insulin Medical sciences Metabolic diseases Metabolic syndrome Metabolic Syndrome - metabolism Metabolic syndrome X Miscellaneous Nitroprusside - pharmacology Original Research Other metabolic disorders Oxidative Stress - drug effects Peptide hormones Physiological aspects Public health. Hygiene Public health. Hygiene-occupational medicine Studies Vasodilation - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!